Clinical Trial Update: Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial evaluating the combination of leuprolide, bicalutamide, and implant radiation therapy for locally recurrent prostate cancer fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide (Leuprolide acetate)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED